Wednesday, July 8, 2026

pharma · Covid-19 · Chronic Myocardial Ischemia · LSTA

Lisata Therapeutics

Lisata Therapeutics is a pharma organization headquartered in basking ridge, USA. It trades on NYSE under ticker LSTA. Primary therapeutic focus areas include Covid-19, Chronic Myocardial Ischemia, Stage IV Melanoma, Kid

110 Allen Road, 2nd Flr, Basking Ridge, NJ 07920, US HQ
2006 Founded
38 Employees
Public company Type
LSTA · NYSE Ticker
Company details
Status
Public
HQ
110 Allen Road, 2nd Flr, Basking Ridge, NJ 07920, US
Founded
2006
Employees
38
Programs
15
Drugs
13
Patents
1
Clinical program

CEND-1

Phase 1 · small molecule · Pancreatic Cancer

CEND-1 for Pancreatic Cancer is a Phase 1 program (small_molecule) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

← All LISATA THERAPEUTICS, INC. projects Phase 1 small molecule completed

Internal code CEND1-001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
LISATA THERAPEUTICS, INC.
Phase
Phase 1
Modality
small_molecule
Indication
Pancreatic Cancer
Status
completed
Trials
1

Clinical trials